menu
    • menu

    Company profile for PEEL Therapeutics

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PEEL Therapeutics was born out of the desire to improve lives with evolutionary solutions that nature has been developing for millions of years. PEEL is a USA-Israeli emerging biotech that develops our evolution-inspired medicines to help patients all over the world. The PEEL pipeline originates from assets inspired by the evolution of elephants, plants, and humans for the treatment of cancer and a wide range of inflammatory ...
    PEEL Therapeutics was born out of the desire to improve lives with evolutionary solutions that nature has been developing for millions of years. PEEL is a USA-Israeli emerging biotech that develops our evolution-inspired medicines to help patients all over the world. The PEEL pipeline originates from assets inspired by the evolution of elephants, plants, and humans for the treatment of cancer and a wide range of inflammatory diseases. We take our name from the Hebrew word for elephant (פיל), a large and naturally cancer resistant creature

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PEEL TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2000 Circle of Hope Dr. Room 3536 Salt Lake City, UT 84112
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.peeltx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/peel-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Peel Therapeutics to Present Data on its TOP1 Inhibitor PEEL-224
    Peel Therapeutics to Present Data on its TOP1 Inhibitor PEEL-224

    01 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/peel-therapeutics-to-present-data-on-its-top1-inhibitor-peel-224-at-the-connective-tissue-oncology-society-annual-meeting-and-society-for-immunotherapy-of-cancer-annual-meeting-301974342.html

    PR NEWSWIRE
    01 Nov 2023
    Share Share
    Peel Therapeutics Reports Excessive NETosis Induction in Long COVID
    Peel Therapeutics Reports Excessive NETosis Induction in Long COVID

    13 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/peel-therapeutics-describes-excessive-netosis-induction-in-long-covid-301796901.html

    PR NEWSWIRE
    13 Apr 2023
    Share Share
    Peel Therapeutics Initiates Clinical Trial of PEEL-224
    Peel Therapeutics Initiates Clinical Trial of PEEL-224

    10 Aug 2022

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/peel-therapeutics-initiates-clinical-trial-of-peel-224-in-patients-with-advanced-solid-tumors-301603133.html

    PR NEWSWIRE
    10 Aug 2022
    Share Share
    PEEL Therapeutics Developing Cancer Drug from Plant Toxin
    PEEL Therapeutics Developing Cancer Drug from Plant Toxin

    24 Aug 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/peel-therapeutics-developing-cancer-drug-from-plant-toxin-301117106.html

    PRNEWSWIRE
    24 Aug 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search